Recent studies have revealed that intranasally applied galanin-like peptide (GALP), which is an endogenous ligand of GALRs, has a central anti-obesity action in addition to its role in food intake regulation [36]. The gene discussed is GALP; the disease is obesity due to melanocortin 4 receptor deficiency.